Version 5.4
Bos taurus Protein: BT.55194
Summary
InnateDB Protein IDBP-681943.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol BT.55194
Protein Name alanine--glyoxylate aminotransferase 2, mitochondrial
Synonyms
Species Bos taurus
Ensembl Protein ENSBTAP00000010113
InnateDB Gene IDBG-630478 (BT.55194)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 4 interaction(s) predicted by orthology.
Predicted by orthology
Total 4 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0003824 catalytic activity
GO:0008453 alanine-glyoxylate transaminase activity
GO:0008483 transaminase activity
GO:0030170 pyridoxal phosphate binding
Biological Process
GO:0009436 glyoxylate catabolic process
GO:0019265 glycine biosynthetic process, by transamination of glyoxylate
GO:0019481 L-alanine catabolic process, by transamination
GO:0045429 positive regulation of nitric oxide biosynthetic process
Cellular Component
GO:0005739 mitochondrion
Protein Structure and Domains
PDB ID
InterPro IPR005814 Aminotransferase class-III
IPR015424 Pyridoxal phosphate-dependent transferase
PFAM PF00202
PRINTS
PIRSF PIRSF000521
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL F1MLG7
UniProt Splice Variant
Entrez Gene 521553
UniGene Bt.55194
RefSeq NP_001069289
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL DAAA02050661
GenPept

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca